scispace - formally typeset
A

Achille P. Caputi

Researcher at University of Messina

Publications -  407
Citations -  19416

Achille P. Caputi is an academic researcher from University of Messina. The author has contributed to research in topics: Nitrotyrosine & Artery occlusion. The author has an hindex of 74, co-authored 405 publications receiving 18740 citations. Previous affiliations of Achille P. Caputi include Queen Mary University of London & University of Salerno.

Papers
More filters
Journal ArticleDOI

Serotonin mediates beneficial effects of Hypericum perforatum on nicotine withdrawal signs.

Carmen Mannucci, +4 more
- 15 Oct 2007 - 
TL;DR: It is possible to suggest an involvement of 5-HT in beneficial effects of H. perforatum on suffering produced by nicotine withdrawal in dependent mice.
Journal ArticleDOI

Beyond antibodies: ankyrins and DARPins. From basic research to drug approval.

Achille P. Caputi, +1 more
- 01 Apr 2020 - 
TL;DR: The pathway that, starting from the deep understanding of ankyrins, led to the development of a new class of recombinant-binding proteins, the DARPins, which are envisaged as alternatives to mAbs and related biologics, with the potential to overcome certain shortcomings of mAbs.
Journal ArticleDOI

Spontaneous reporting of adverse drug reactions in elderly patients in sicily (italy)

Paola Maria Cutroneo, +4 more
- 01 Jul 1999 - 
TL;DR: Investigation of spontaneous reports of suspected adverse drug reactions in elderly patients in Sicily during the period from 1 January 1995 to 31 December 1997 found a correlation between multi-drug consumption, comorbidity and seriousness of ADRs.
Journal ArticleDOI

Need for Redesigning Pharmacologic Research in Older Individuals. A Position Statement of the Geriatric Working Group of the Agenzia Italiana del Farmaco (AIFA)

Roberto Bernabei, +11 more
- 01 Jan 2011 - 
TL;DR: Eminent geriatricians have voiced that the current practice produces an evidence-biased rather and evidencebased medicine and have called for the conduction of appropriately designed trials involving real geriatric patients.
Journal ArticleDOI

Protective effects of bay u 3405, a thromboxane A2 receptor antagonist, in endotoxin shock

D. Aaltavilla, +8 more
- 01 Aug 1994 - 
TL;DR: The gastric alterations were significantly reduced in rats pretreated with BAY U 3405, suggesting that this thromboxane receptor antagonist might be a useful drug in shock conditions.